← SynDRA
TIAGABINE
SynDRA canonical compound SYN0003258 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | SLC6A1 |
| Mechanism of action | GABA uptake inhibitor |
| Indication | seizures |
| Disease area | neurology/psychiatry |
All known targets
- SLC6A1
- CYP2C19
- Slc6a1
- Slc6a12
Mechanisms of action (all sources)
- GABA uptake inhibitor
- SLC6A1 INHIBITOR
- GABA transporter 1 inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ESR1
- ABL1
- PDE3A
- HTR1A
- HTR2B
- KCNH2
- KDR
- MAOA
- MAPK1
- OPRM1
- PDE4A
- HDAC6
- PGR
- PTGS1
- SLC6A11
- SLC6A2
- SLC6A3
- SLC6A4
- TBXA2R
- TDP1
- HRH3
- GSK3B
- ACHE
- CDK2
- ADORA3
- ADRA1A
- ADRA2A
- AR
- AURKA
- BRD4
- BRPF1
- CHRM1
- GMNN
- CHRM2
- CSNK1D
- CYP3A4
- DRD1
- DRD3
- F2
- FGFR2
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anticonvulsants
- Central Nervous System Agents
- GABA Agents
- GABA Uptake Inhibitors
- Membrane Transport Modulators
- Neurotransmitter Agents
- Neurotransmitter Uptake Inhibitors
- Anti-epileptic Agent
ATC classes
Cross-references
Synonyms
- GABITRIL
- Gabitril
- TIAGABINE HYDROCHLORIDE
- (R)-Tiagabine
- gabatril
- tiagabine hydrochloride
- tiagabine HCl
- Tiagabina
- Abbott-70569-1
- A-70569-1
- ABBOTT-70569 FREE BASE
- ABBOTT-705691 FREE BASE
- ABT-569 FREE BASE
- NNC-050328 FREE BASE
- NO-050328 FREE BASE
- Tiagabinum
- Tiagabinum [INN-Latin]
- Tiagabina [INN-Spanish]
- Tiagabine [INN:BAN]
- Tiagabine [INN]
- Abbott-70569
- UNII-Z80I64HMNP
- Tiagabine (INN)
- ABBOTT-70569-1
- Gabitril (TN)
- CHEMBL1027
- Z80I64HMNP
- ABT-569
- CHEBI:9586
- NO-328
- Gabatril
- NO-329
- Tiagabina [INN-Spanish];Tiagabine (INN)
- [3H]tiagabine
- NO328
- NO050328
- TGB
- NCGC00164626-01
Reported adverse events
- Agitation
- Asthenia
- Ataxia
- Cough
- Depression
- Dizziness
- Hostility
- Insomnia
- Nausea
- Nervousness
- Nystagmus
- Pain
Look up TIAGABINE in the interactive SynDRA portal →